Literature DB >> 11198718

Increased circulating leptin levels in chronic alcoholism.

J M Nicolás1, J Fernández-Solà, F Fatjó, R Casamitjana, R Bataller, E Sacanella, E Tobías, E Badía, R Estruch.   

Abstract

BACKGROUND: Malnutrition seen in chronic alcoholics is partly due to reduced energy intake. Leptin is a peptide hormone implicated in the regulation of appetite and expenditure of energy. The prevalence and significance of abnormal circulating leptin levels in alcoholics, as well as the relationship of these levels with nutritional status, liver disease, and ethanol consumption, remain uncertain.
METHODS: Serum leptin levels were measured in 60 active asymptomatic alcoholics, 20 active alcoholics with cirrhosis of the liver, 20 abstinent alcoholics, and 60 controls. Nutritional status and ethanol consumption also were assessed.
RESULTS: In the control group, circulating leptin levels (mean 4.7+/-0.3 microg/liter) correlated with body fat stores. Despite showing a lower fat area of the arm, active alcoholics had significantly higher leptin levels than the controls (p < 0.001), regardless of the presence of cirrhosis. By contrast, none of the abstinent alcoholics showed hyperleptinemia. In the multivariate regression analysis, the fat area of the arm (p < 0.001), the lifetime ethanol consumption (p = 0.007), and the number of cigarettes smoked per day (p = 0.02) were found to be independent factors that influenced leptin levels in active alcoholics. After we adjusted for age, fat area of the arm, and tobacco consumption, a significant correlation was observed between lifetime consumption of ethanol and serum leptin concentrations (r = 0.36, p < 0.001).
CONCLUSIONS: Circulating leptin levels are increased in a dose-dependent manner in chronic alcoholism, regardless of nutritional status or the presence of compensated liver disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11198718

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  31 in total

Review 1.  The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans.

Authors:  George A Kenna; Robert M Swift; Thomas Hillemacher; Lorenzo Leggio
Journal:  Neuropsychol Rev       Date:  2012-07-07       Impact factor: 7.444

2.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  Relation of dietary and lifestyle traits to difference in serum leptin of Japanese in Japan and Hawaii: the INTERLIPID study.

Authors:  Y Nakamura; H Ueshima; N Okuda; K Miura; Y Kita; T Okamura; T C Turin; A Okayama; B Rodriguez; J D Curb; J Stamler
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-08-03       Impact factor: 4.222

Review 4.  Alcohol abuse: critical pathophysiological processes and contribution to disease burden.

Authors:  Patricia E Molina; Jason D Gardner; Flavia M Souza-Smith; Annie M Whitaker
Journal:  Physiology (Bethesda)       Date:  2014-05

Review 5.  Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?

Authors:  Sotirios K Bethanis; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 6.  Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model.

Authors:  Patricia E Molina; Angela M Amedee; Peter Winsauer; Steve Nelson; Gregory Bagby; Liz Simon
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-21       Impact factor: 4.147

7.  Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.

Authors:  Min You; Robert V Considine; Teresa C Leone; Daniel P Kelly; David W Crabb
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

8.  Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures.

Authors:  Angela M Lyons; Emily G Lowery; Dennis R Sparta; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2008-11       Impact factor: 3.455

Review 9.  Biomedical consequences of alcohol use disorders in the HIV-infected host.

Authors:  Patricia E Molina; Gregory J Bagby; Steve Nelson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

10.  PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair.

Authors:  Maoyin Pang; Suzanne M de la Monte; Lisa Longato; Ming Tong; Jiman He; Rajeeve Chaudhry; Kevin Duan; Jiyun Ouh; Jack R Wands
Journal:  J Hepatol       Date:  2009-03-20       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.